2018-2023 Global Alzheimer's Disease Drug Consumption Market Report

Publisher Name :
Date: 06-Jun-2018
No. of pages: 135

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Alzheimer's Disease Drug market for 2018-2023.

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

In the last several years, global market of alzheimer's disease drug change huge.

The classification of alzheimer's disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.

Alzheimer's disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer's disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.

Over the next five years, LPI(LP Information) projects that Alzheimer's Disease Drug will register a -11.3% CAGR in terms of revenue, reach US$ 1580 million by 2023, from US$ 2870 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Donepezil

- Memantine

- Rivastigmine

Segmentation by application:

- Early to Moderate Stages

- Moderate to Severe Stages

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Allergan

- Eisai

- Novartis

- Daiichi Sankyo

- Merz Pharma

- Pfizer

- Johnson & Johnson

- Lundbeck

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Alzheimer's Disease Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Alzheimer's Disease Drug market by identifying its various subsegments.

- Focuses on the key global Alzheimer's Disease Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Alzheimer's Disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Alzheimer's Disease Drug submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Alzheimer's Disease Drug Consumption Market Report

Table of Contents

2018-2023 Global Alzheimer's Disease Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alzheimer's Disease Drug Consumption 2013-2023
2.1.2 Alzheimer's Disease Drug Consumption CAGR by Region
2.2 Alzheimer's Disease Drug Segment by Type
2.2.1 Donepezil
2.2.2 Memantine
2.2.3 Rivastigmine
2.3 Alzheimer's Disease Drug Consumption by Type
2.3.1 Global Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
2.3.2 Global Alzheimer's Disease Drug Revenue and Market Share by Type (2013-2018)
2.3.3 Global Alzheimer's Disease Drug Sale Price by Type (2013-2018)
2.4 Alzheimer's Disease Drug Segment by Application
2.4.1 Early to Moderate Stages
2.4.2 Moderate to Severe Stages
2.5 Alzheimer's Disease Drug Consumption by Application
2.5.1 Global Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
2.5.2 Global Alzheimer's Disease Drug Value and Market Share by Application (2013-2018)
2.5.3 Global Alzheimer's Disease Drug Sale Price by Application (2013-2018)

3 Global Alzheimer's Disease Drug by Players
3.1 Global Alzheimer's Disease Drug Sales Market Share by Players
3.1.1 Global Alzheimer's Disease Drug Sales by Players (2016-2018)
3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Players (2016-2018)
3.2 Global Alzheimer's Disease Drug Revenue Market Share by Players
3.2.1 Global Alzheimer's Disease Drug Revenue by Players (2016-2018)
3.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Players (2016-2018)
3.3 Global Alzheimer's Disease Drug Sale Price by Players
3.4 Global Alzheimer's Disease Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Alzheimer's Disease Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Alzheimer's Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Alzheimer's Disease Drug by Regions
4.1 Alzheimer's Disease Drug by Regions
4.1.1 Global Alzheimer's Disease Drug Consumption by Regions
4.1.2 Global Alzheimer's Disease Drug Value by Regions
4.2 Americas Alzheimer's Disease Drug Consumption Growth
4.3 APAC Alzheimer's Disease Drug Consumption Growth
4.4 Europe Alzheimer's Disease Drug Consumption Growth
4.5 Middle East & Africa Alzheimer's Disease Drug Consumption Growth

5 Americas
5.1 Americas Alzheimer's Disease Drug Consumption by Countries
5.1.1 Americas Alzheimer's Disease Drug Consumption by Countries (2013-2018)
5.1.2 Americas Alzheimer's Disease Drug Value by Countries (2013-2018)
5.2 Americas Alzheimer's Disease Drug Consumption by Type
5.3 Americas Alzheimer's Disease Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Alzheimer's Disease Drug Consumption by Countries
6.1.1 APAC Alzheimer's Disease Drug Consumption by Countries (2013-2018)
6.1.2 APAC Alzheimer's Disease Drug Value by Countries (2013-2018)
6.2 APAC Alzheimer's Disease Drug Consumption by Type
6.3 APAC Alzheimer's Disease Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Alzheimer's Disease Drug by Countries
7.1.1 Europe Alzheimer's Disease Drug Consumption by Countries (2013-2018)
7.1.2 Europe Alzheimer's Disease Drug Value by Countries (2013-2018)
7.2 Europe Alzheimer's Disease Drug Consumption by Type
7.3 Europe Alzheimer's Disease Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Alzheimer's Disease Drug by Countries
8.1.1 Middle East & Africa Alzheimer's Disease Drug Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Alzheimer's Disease Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Alzheimer's Disease Drug Consumption by Type
8.3 Middle East & Africa Alzheimer's Disease Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Alzheimer's Disease Drug Distributors
10.3 Alzheimer's Disease Drug Customer

11 Global Alzheimer's Disease Drug Market Forecast
11.1 Global Alzheimer's Disease Drug Consumption Forecast (2018-2023)
11.2 Global Alzheimer's Disease Drug Forecast by Regions
11.2.1 Global Alzheimer's Disease Drug Forecast by Regions (2018-2023)
11.2.2 Global Alzheimer's Disease Drug Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Alzheimer's Disease Drug Forecast by Type
11.8 Global Alzheimer's Disease Drug Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Alzheimer's Disease Drug Product Offered
12.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Eisai
12.2.1 Company Details
12.2.2 Alzheimer's Disease Drug Product Offered
12.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Eisai News
12.3 Novartis
12.3.1 Company Details
12.3.2 Alzheimer's Disease Drug Product Offered
12.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Daiichi Sankyo
12.4.1 Company Details
12.4.2 Alzheimer's Disease Drug Product Offered
12.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Daiichi Sankyo News
12.5 Merz Pharma
12.5.1 Company Details
12.5.2 Alzheimer's Disease Drug Product Offered
12.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Merz Pharma News
12.6 Pfizer
12.6.1 Company Details
12.6.2 Alzheimer's Disease Drug Product Offered
12.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Pfizer News
12.7 Johnson & Johnson
12.7.1 Company Details
12.7.2 Alzheimer's Disease Drug Product Offered
12.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Johnson & Johnson News
12.8 Lundbeck
12.8.1 Company Details
12.8.2 Alzheimer's Disease Drug Product Offered
12.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Lundbeck News

13 Research Findings and Conclusion


List of Tables and Figures

Figure Picture of Alzheimer's Disease Drug
Table Product Specifications of Alzheimer's Disease Drug
Figure Alzheimer's Disease Drug Report Years Considered
Figure Market Research Methodology
Figure Global Alzheimer's Disease Drug Consumption Growth Rate 2013-2023 (M Units)
Figure Global Alzheimer's Disease Drug Value Growth Rate 2013-2023 ($ Millions)
Table Alzheimer's Disease Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Donepezil
Table Major Players of Donepezil
Figure Product Picture of Memantine
Table Major Players of Memantine
Figure Product Picture of Rivastigmine
Table Major Players of Rivastigmine
Table Global Consumption Sales by Type (2013-2018)
Table Global Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Figure Global Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Drug Revenue by Type (2013-2018) ($ million)
Table Global Alzheimer's Disease Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Alzheimer's Disease Drug Value Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Drug Sale Price by Type (2013-2018)
Figure Alzheimer's Disease Drug Consumed in Early to Moderate Stages
Figure Global Alzheimer's Disease Drug Market: Early to Moderate Stages (2013-2018) (M Units)
Figure Global Alzheimer's Disease Drug Market: Early to Moderate Stages (2013-2018) ($ Millions)
Figure Global Early to Moderate Stages YoY Growth ($ Millions)
Figure Alzheimer's Disease Drug Consumed in Moderate to Severe Stages
Figure Global Alzheimer's Disease Drug Market: Moderate to Severe Stages (2013-2018) (M Units)
Figure Global Alzheimer's Disease Drug Market: Moderate to Severe Stages (2013-2018) ($ Millions)
Figure Global Moderate to Severe Stages YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Figure Global Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Table Global Alzheimer's Disease Drug Value by Application (2013-2018)
Table Global Alzheimer's Disease Drug Value Market Share by Application (2013-2018)
Figure Global Alzheimer's Disease Drug Value Market Share by Application (2013-2018)
Table Global Alzheimer's Disease Drug Sale Price by Application (2013-2018)
Table Global Alzheimer's Disease Drug Sales by Players (2016-2018) (M Units)
Table Global Alzheimer's Disease Drug Sales Market Share by Players (2016-2018)
Figure Global Alzheimer's Disease Drug Sales Market Share by Players in 2016
Figure Global Alzheimer's Disease Drug Sales Market Share by Players in 2017
Table Global Alzheimer's Disease Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Alzheimer's Disease Drug Revenue Market Share by Players (2016-2018)
Figure Global Alzheimer's Disease Drug Revenue Market Share by Players in 2016
Figure Global Alzheimer's Disease Drug Revenue Market Share by Players in 2017
Table Global Alzheimer's Disease Drug Sale Price by Players (2016-2018)
Figure Global Alzheimer's Disease Drug Sale Price by Players in 2017
Table Global Alzheimer's Disease Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Alzheimer's Disease Drug Products Offered
Table Alzheimer's Disease Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Alzheimer's Disease Drug Consumption by Regions 2013-2018 (M Units)
Table Global Alzheimer's Disease Drug Consumption Market Share by Regions 2013-2018
Figure Global Alzheimer's Disease Drug Consumption Market Share by Regions 2013-2018
Table Global Alzheimer's Disease Drug Value by Regions 2013-2018 ($ Millions)
Table Global Alzheimer's Disease Drug Value Market Share by Regions 2013-2018
Figure Global Alzheimer's Disease Drug Value Market Share by Regions 2013-2018
Figure Americas Alzheimer's Disease Drug Consumption 2013-2018 (M Units)
Figure Americas Alzheimer's Disease Drug Value 2013-2018 ($ Millions)
Figure APAC Alzheimer's Disease Drug Consumption 2013-2018 (M Units)
Figure APAC Alzheimer's Disease Drug Value 2013-2018 ($ Millions)
Figure Europe Alzheimer's Disease Drug Consumption 2013-2018 (M Units)
Figure Europe Alzheimer's Disease Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Alzheimer's Disease Drug Consumption 2013-2018 (M Units)
Figure Middle East & Africa Alzheimer's Disease Drug Value 2013-2018 ($ Millions)
Table Americas Alzheimer's Disease Drug Consumption by Countries (2013-2018) (M Units)
Table Americas Alzheimer's Disease Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Alzheimer's Disease Drug Consumption Market Share by Countries in 2017
Table Americas Alzheimer's Disease Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Alzheimer's Disease Drug Value Market Share by Countries (2013-2018)
Figure Americas Alzheimer's Disease Drug Value Market Share by Countries in 2017
Table Americas Alzheimer's Disease Drug Consumption by Type (2013-2018) (M Units)
Table Americas Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Figure Americas Alzheimer's Disease Drug Consumption Market Share by Type in 2017
Table Americas Alzheimer's Disease Drug Consumption by Application (2013-2018) (M Units)
Table Americas Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Figure Americas Alzheimer's Disease Drug Consumption Market Share by Application in 2017
Figure United States Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure United States Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Canada Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Mexico Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Table APAC Alzheimer's Disease Drug Consumption by Countries (2013-2018) (M Units)
Table APAC Alzheimer's Disease Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Alzheimer's Disease Drug Consumption Market Share by Countries in 2017
Table APAC Alzheimer's Disease Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Alzheimer's Disease Drug Value Market Share by Countries (2013-2018)
Figure APAC Alzheimer's Disease Drug Value Market Share by Countries in 2017
Table APAC Alzheimer's Disease Drug Consumption by Type (2013-2018) (M Units)
Table APAC Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Figure APAC Alzheimer's Disease Drug Consumption Market Share by Type in 2017
Table APAC Alzheimer's Disease Drug Consumption by Application (2013-2018) (M Units)
Table APAC Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Figure APAC Alzheimer's Disease Drug Consumption Market Share by Application in 2017
Figure China Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure China Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Japan Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Korea Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Southeast Asia Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure India Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure India Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Australia Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Table Europe Alzheimer's Disease Drug Consumption by Countries (2013-2018) (M Units)
Table Europe Alzheimer's Disease Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Alzheimer's Disease Drug Consumption Market Share by Countries in 2017
Table Europe Alzheimer's Disease Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Alzheimer's Disease Drug Value Market Share by Countries (2013-2018)
Figure Europe Alzheimer's Disease Drug Value Market Share by Countries in 2017
Table Europe Alzheimer's Disease Drug Consumption by Type (2013-2018) (M Units)
Table Europe Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Figure Europe Alzheimer's Disease Drug Consumption Market Share by Type in 2017
Table Europe Alzheimer's Disease Drug Consumption by Application (2013-2018) (M Units)
Table Europe Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Figure Europe Alzheimer's Disease Drug Consumption Market Share by Application in 2017
Figure Germany Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Germany Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure France Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure France Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure UK Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure UK Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Italy Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Russia Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Spain Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Alzheimer's Disease Drug Consumption by Countries (2013-2018) (M Units)
Table Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Alzheimer's Disease Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Alzheimer's Disease Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Alzheimer's Disease Drug Value Market Share by Countries in 2017
Table Middle East & Africa Alzheimer's Disease Drug Consumption by Type (2013-2018) (M Units)
Table Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Alzheimer's Disease Drug Consumption by Application (2013-2018) (M Units)
Table Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Alzheimer's Disease Drug Consumption Market Share by Application in 2017
Figure Egypt Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Egypt Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure South Africa Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Israel Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure Turkey Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Alzheimer's Disease Drug Consumption Growth 2013-2018 (M Units)
Figure GCC Countries Alzheimer's Disease Drug Value Growth 2013-2018 ($ Millions)
Table Alzheimer's Disease Drug Distributors List
Table Alzheimer's Disease Drug Customer List
Figure Global Alzheimer's Disease Drug Consumption Growth Rate Forecast (2018-2023) (M Units)
Figure Global Alzheimer's Disease Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Alzheimer's Disease Drug Consumption Forecast by Countries (2018-2023) (M Units)
Table Global Alzheimer's Disease Drug Consumption Market Forecast by Regions
Table Global Alzheimer's Disease Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Alzheimer's Disease Drug Value Market Share Forecast by Regions
Figure Americas Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Americas Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure APAC Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure APAC Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Europe Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Europe Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Middle East & Africa Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure United States Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure United States Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Canada Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Canada Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Mexico Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Mexico Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Brazil Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Brazil Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure China Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure China Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Japan Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Japan Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Korea Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Korea Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Southeast Asia Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure India Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure India Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Australia Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Australia Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Germany Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Germany Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure France Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure France Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure UK Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure UK Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Italy Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Italy Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Russia Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Russia Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Spain Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Spain Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Egypt Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Egypt Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure South Africa Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure South Africa Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Israel Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Israel Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure Turkey Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure Turkey Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Alzheimer's Disease Drug Consumption 2018-2023 (M Units)
Figure GCC Countries Alzheimer's Disease Drug Value 2018-2023 ($ Millions)
Table Global Alzheimer's Disease Drug Consumption Forecast by Type (2018-2023) (M Units)
Table Global Alzheimer's Disease Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Alzheimer's Disease Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Alzheimer's Disease Drug Value Market Share Forecast by Type (2018-2023)
Table Global Alzheimer's Disease Drug Consumption Forecast by Application (2018-2023) (M Units)
Table Global Alzheimer's Disease Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Alzheimer's Disease Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Alzheimer's Disease Drug Value Market Share Forecast by Application (2018-2023)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Alzheimer's Disease Drug Market Share (2016-2018)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eisai Alzheimer's Disease Drug Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Alzheimer's Disease Drug Market Share (2016-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Daiichi Sankyo Alzheimer's Disease Drug Market Share (2016-2018)
Table Merz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merz Pharma Alzheimer's Disease Drug Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Alzheimer's Disease Drug Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Alzheimer's Disease Drug Market Share (2016-2018)
Table Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lundbeck Alzheimer's Disease Drug Market Share (2016-2018)
  • Global Alzheimer's Disease Drug Market Professional Survey Report 2018
    Published: 26-Jun-2018        Price: US 3500 Onwards        Pages: 108
    This report studies the global Alzheimer's Disease Drug market status and forecast, categorizes the global Alzheimer's Disease Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Alzheimer's Disease Drug market is valued at xx million US$ in 2017 and is expected to......
  • Global Alzheimer's Disease Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Alzheimer's Disease Drug Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Investigation Report on Nicergoline in China, 2018-2022
    Published: 21-Jun-2018        Price: US 2200 Onwards        Pages: 30
    Description Nicergoline is a semi-synthetic ergoline derivative that plays as a-blocker and can strengthen vascular systems, brain cell metabolism, oxygen and glucose digestion and dopamine conversion so that nerve conduction and brain function can be improved. Nicergoline was originally developed by Pfizer. It can be applied to a wide range of symptoms, so it became popular worldwide since its launch. According to CRI's analysis, due to the expired patent of nicer......
  • 2018-2023 Global Alzheimer's Disease Consumption Market Report
    Published: 11-Jun-2018        Price: US 4660 Onwards        Pages: 132
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Alzheimer's Disease market for 2018-2023. Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60-70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). Over the next five years, LPI(LP Information) projects......
  • 2018 Top 5 Alzheimer's Disease Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 11-Jun-2018        Price: US 4960 Onwards        Pages: 124
    Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60-70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). Over the next five years, LPI(LP Information) projects that Alzheimer's Disease will register a 15.5% CAGR in terms of revenue, reach US$ 6880 million by 2023, from US$ 2900 million in 2017. This report studies the global ......
  • United States Alzheimer's Disease Drug Market Report 2018
    Published: 07-Jun-2018        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Alzheimer's Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • 2018 Top 5 Alzheimer's Disease Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 06-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. In the last several years, global market of alzheimer's disease drug change huge. The classification of alzheimer's disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast......
  • Global Alzheimer's Disease Drug Sales Market Report 2018
    Published: 04-Jun-2018        Price: US 4000 Onwards        Pages: 108
    This report studies the global Alzheimer's Disease Drug market status and forecast, categorizes the global Alzheimer's Disease Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs